RESUMEN
By a hydroamination-induced tandem annulation process, we herein report a new three-component reaction for room temperature construction of carbo-bridged polyheterocycles with exclusive diastereoselectivity, which features readily available feedstocks, catalyst-free conditions, good substrate and functionality compatibility, no need for transition metal catalysts, and high step and atom efficiency. The products are formed via initial formation of 1,2-dihydro-3H-pyrazol-3-one nucleophiles from but-2-ynedioates and hydrazine followed by 2,4-difunctionalization of N-heteroarenium salts. Given that the obtained products possess structurally important tetrahydroquinoline and pyranopyrazole motifs, the developed chemistry is anticipated to be further applied to the discovery of functional molecules including biomedical ones.
RESUMEN
Despite the widespread applications of α-hydroxyalkyl cyclic amines, direct and diverse access to such a class of unique vicinal amino alcohols still remains, to date, a challenge. Here, through a strategy of electroreductive α-hydroxyalkylation of inactive N-heteroarenes with ketones or electron-rich arylaldehydes, we describe a room temperature approach for the direct construction of α-hydroxyalkyl cyclic amines, which features a broad substrate scope, operational simplicity, high chemoselectivity, and no need for pressurized H2 gas and transition metal catalysts. The zinc ion generated from anode oxidation plays a crucial role in the activation of both reactants by decreasing their reduction potentials. The strategy of electroreduction in combination with substrate activation by Lewis acids in this work is anticipated to develop more useful transformations.
RESUMEN
An efficient strategy for the synthesis of benzofuro[2,3- b]pyrazines was developed. These tricyclic scaffolds were formed through a multistep cascade sequence, which includes double insertion of isonitriles and chemoselective bicyclization. In this reaction, a nanopalladium was used as a recyclable catalyst. Product 3w exhibited excellent anticancer activity toward T-24 (IC50 = 12.5 ± 0.9 µM) and HeLa (IC50 = 14.7 ± 1.6 µM) cells. We also explored the action mechanism of 3w on T-24 cells.